Phreesia Named to Capterra 2025 Shortlist for Patient Engagement and Medical Scheduling
ByAinvest
Tuesday, Aug 12, 2025 4:07 pm ET1min read
PHR--
The Capterra Shortlist is an independent assessment that evaluates user reviews and online search activity to identify market leaders in various software categories. Phreesia's inclusion in this prestigious list is a testament to its positive reputation among healthcare providers, as evidenced by its overall rating of 4.3 out of 5 on Capterra.
Phreesia's CEO, Chaim Indig, expressed his pride in the achievement, stating, "Being named to two of the 2025 Capterra Shortlists is an honor that reflects the positive reviews and feedback we receive from our healthcare provider clients. Our digital solutions help engage and empower patients to take a more active role in their care, and this award is a welcome recognition of those efforts."
Phreesia has been instrumental in managing approximately 170 million patient visits in 2024, representing one in seven visits across the U.S. The company's digital solutions, which include patient-driven intake, outreach, education, and more, have significantly enhanced the patient experience, driven efficiency, and improved healthcare outcomes.
For more information about Phreesia, visit [Phreesia's official website](https://www.phreesia.com).
References:
[1] https://www.businesswire.com/news/home/20250812215331/en/Phreesia-Named-to-the-2025-Capterra-Shortlist-for-Patient-Engagement-and-Medical-Scheduling
[2] https://www.stocktitan.net/news/PHR/phreesia-named-to-the-2025-capterra-shortlist-for-patient-engagement-k02frsbgoa55.html
Phreesia has been named to the 2025 Capterra Shortlist in the Patient Engagement and Medical Scheduling categories. The Capterra Shortlist evaluates user reviews and search activity to identify market leaders. Phreesia's digital solutions engage and empower patients to take an active role in their care, and it has an overall rating of 4.3 out of 5 on Capterra.
Phreesia, a leading provider of patient intake, outreach, and activation solutions, has been named to the 2025 Capterra Shortlist in the Patient Engagement and Medical Scheduling categories. This recognition underscores the company's commitment to enhancing patient experiences and empowering patients to take a more active role in their healthcare.The Capterra Shortlist is an independent assessment that evaluates user reviews and online search activity to identify market leaders in various software categories. Phreesia's inclusion in this prestigious list is a testament to its positive reputation among healthcare providers, as evidenced by its overall rating of 4.3 out of 5 on Capterra.
Phreesia's CEO, Chaim Indig, expressed his pride in the achievement, stating, "Being named to two of the 2025 Capterra Shortlists is an honor that reflects the positive reviews and feedback we receive from our healthcare provider clients. Our digital solutions help engage and empower patients to take a more active role in their care, and this award is a welcome recognition of those efforts."
Phreesia has been instrumental in managing approximately 170 million patient visits in 2024, representing one in seven visits across the U.S. The company's digital solutions, which include patient-driven intake, outreach, education, and more, have significantly enhanced the patient experience, driven efficiency, and improved healthcare outcomes.
For more information about Phreesia, visit [Phreesia's official website](https://www.phreesia.com).
References:
[1] https://www.businesswire.com/news/home/20250812215331/en/Phreesia-Named-to-the-2025-Capterra-Shortlist-for-Patient-Engagement-and-Medical-Scheduling
[2] https://www.stocktitan.net/news/PHR/phreesia-named-to-the-2025-capterra-shortlist-for-patient-engagement-k02frsbgoa55.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet